Comparison between Alterations in some Hematological and Biochemical Parameters in COVID-19 and non-COVID-19 Patients Albaida, Libya
The COVID-19 outbreak has resulted in an unexpected health crisis all around the world. It was on March 11, 2020, when the WHO declared it as a pandemic. Ever since, an exponential increase in the disease has been seen. The coronavirus disease 2019 or COVID-19 is a beta-coronavirus that has been closely related to the SARS-CoV-2 by means of genetic sequencing methods. This disease is associated with alterations in the complete blood picture and coagulopathies. In this present study, the role of hematological and biochemical parameters of blood in predicting COVID-19 infection was investigated, as these blood analyzes are considered a vital indicator for confirmation of infection. The present work was designed to diagnose COVID- 19 with five basic blood tests: white blood cells (WBC), lymphocytes (LYM), neutrophils (NEUT), platelets (PLT), and clotting factor D – dimer as well as the diagnosis of COVID-19 associated tests. Biochemical blood C-reactive protein (CRP), serum ferritin (FRR), and Lactic dehydrogenase (LDH). It was noted that the hematological and biochemical blood tests included in this study were capable of diagnosing COVID-19, due to their increase or decrease in the normal rates, both according to what was mentioned in the results. The diagnosis of COVID-19 using blood and blood biochemical tests in people who show some mild clinical symptoms, high and low levels of these parameters have been closely associated with COVID-19 infection and may also serve as biomarkers to predict infection.
Ai, T., Yang, Z., Hou, H., Zhan, C., Chen, C., Lv, W., and Xia, L. (2020). Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology, 296(2): 32-40.
Addison, G. M., Beamish, M. R., Hales, C. N., Hodgkins, M., Jacobs, A., and Llewellin, P. (1972). An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. Journal of Clinical Pathology, 25(4), 326-329.
Assandri, R., Buscarini, E., Canetta, C., Scartabellati, A., Viganò, G., and Montanelli, A. (2020). Laboratory Biomarkers predicting COVID-19 severity in the Emergency room. Archives of medical research, 51(6): 598-599.
Azab, B., Zaher, M., Weiserbs, K. F., Torbey, E., Lacossiere, K., Gaddam, S., and Lafferty, J. (2010). Usefulness of neutrophil to lymphocyte ratio in predicting short-and long- term mortality after non–ST-elevation myocardial infarction. The American journal of cardiology, 106(4): 470-476.
Bo, X. U., Fan, C. Y., Wang, A. L., Zou, Y. L., Yu, Y. H., Cong, H. E., and Qing, M. I. A.O. (2020). Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China. Journal of Infection, 81(1): 51-60.
Bounameaux, H., De Moerloose, P., Perrier, A., and Reber, G. (1994). Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thrombosis and haemostasis, 71(01): 001-006.
Channappanavar, R., and Perlman, S. (2017). Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. In Seminars in immunopathology 39(5): 529-539. Springer Berlin Heidelberg
Eickmann, M., Gravemann, U., Handke, W., Tolksdorf, F., Reichenberg, S., Müller, T. H., and Seltsam, A. (2020). Inactivation of three emerging viruses–severe acute respiratory syndrome coronavirus, Crimean–Congo haemorrhagic fever virus and Nipah virus–in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light. Vox sanguinis, 115(3): 146-151.
García, L. F. (2020). Immune response, inflammation, and the clinical spectrum of COVID-19. Frontiers in immunology, 11: 1441.
Gorbalenya, A.E., Baker, S.C., Baric, R.S., de Groo, R.J., Drosten ,C., and Neuman, B.W.(2020). The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 5,536-544
Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., and Zhong, N. S. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 382(18), 1708-1720.
Henry, B. M. (2020). COVID-19, ECMO, and lymphopenia: a word of caution. The Lancet Respiratory Medicine, 8(4): 24.
Hochachka, P. W., and Somero, G. N. (2002). Biochemical adaptation: mechanism and process in physiological evolution. Oxford university press.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., and Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223): 497-506.
Huang, Y., Tu, M., Wang, S., Chen, S., Zhou, W., Chen, D., and Guo, L. (2020). Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis. Travel medicine and infectious disease, 36: 101606.
Ichikawa, A., Kuba, K., Morita, M., Chida, S., Tezuka, H., Hara, H., and Imai, Y. (2013). CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. American journal of respiratory and critical care medicine, 187(1): 65-77.
Katneni, U. K., Alexaki, A., Hunt, R. C., Schiller, T., DiCuccio, M., Buehler, P. W., and Kimchi-Sarfaty, C. (2020). Coagulopathy and thrombosis as a result of severe COVID-19 infection: a microvascular focus. Thrombosis and Haemostasis. 120(12):1661-1661.
Kernan, K. F., and Carcillo, J. A. (2017). Hyperferritinemia and inflammation. International immunology, 29(9): 401-409.
Lagunas‐Rangel, F.A. (2020). Neutrophil‐to‐ lymphocyte ratio and lymphocyte‐to‐C‐ reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): ameta‐ analysis. Journal of medical virology,19:1733- 1670.
Li, D., Long, Y., Huang, P., Guo, W., Wu, S., Zhou, Q., and Fu, J. (2020). Clinical characteristics of 80 patients with COVID-19 in Zhuzhou City. Chin J Infect Control, 19(03):227-233.
Li, D., Wang, D., Dong, J., Wang, N., Huang, H., Xu, H., and Xia, C. (2020). False-negative results of real-time reverse-transcriptase polymerase chain reaction for severe acute respiratory syndrome coronavirus 2: role of deep-learning-based CT diagnosis and insights from two cases. Korean journal of radiology, 21(4): 505-508.
Lippi, G., Simundic, A. M., and Plebani, M. (2020). Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clinical Chemistry and Laboratory Medicine (CCLM), 58(7): 1070-1076.
Loeffelholz, M. J., and Tang, Y. W. (2020). Laboratory diagnosis of emerging human coronavirus infections–the state of the art. Emerging microbes & infections, 9(1): 747- 756.
Martinez-Outschoorn, U. E., Prisco, M., Ertel, A., Tsirigos, A., Lin, Z., Pavlides, S., and Lisanti, M. P. (2011). Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo- Genomics. Cell cycle, 10(8): 1271-1286.
Naess, A., Nilssen, S. S., Mo, R., Eide, G. E., and Sjursen, H. (2017). Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever. Infection, 45(3): 299-307.
Roncon, L., Zuin, M., Barco, S., Valerio, L., Zuliani, G., Zonzin, P., and Konstantinides, S. V. (2020). Incidence of acute Pulmonary Embolism in COVID-19 patients: systematic review and meta-analysis. Eur J Intern Med, 82:29-37. Embolism and COVID-19. European journal of internal medicine.76-19:91.
Ruan, Q., Yang, K., Wang, W., Jiang, L., and Song, J. (2020). Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive care medicine, 46(6):1294-1297.
Salathé, M., Althaus, C. L., Neher, R., Stringhini, S., Hodcroft, E., Fellay, J., and Low, N. (2020). COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation. Swiss medical weekly, 150(1112).
Sanche, S., Lin, Y. T., Xu, C., Romero- Severson, E., Hengartner, N., and Ke, R. (2020). High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerging infectious diseases, 26(7): 1470.
Shute, P. G. and Maryon, M. (1966). Laboratory Technique for the Study of Malaria. 2nd ed. London: Churchill.
Sproston, N. R., and Ashworth, J. J. (2018). Role of C-reactive protein at sites of inflammation and infection. Frontiers in immunology, 9: 754.
Sun, S., Cai, X., Wang, H., He, G., Lin, Y., Lu, B., and Hu, X. (2020). Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clinica chimica acta, 507, 174-180.
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., and Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 323(11):1061-1069.
World Health Organization, 2. (2020). WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020.
Wu, C., Chen, X., Cai, Y., Zhou, X., Xu, S., Huang, H., and Song, Y. (2020). Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA internal medicine, 180(7), 934-943.
Yang, J., Yang, M., Xu, F., Li, K., Lee, S. K., Ng, P. C., and Fok, T. F. (2003). Effects of oxygen-induced lung damage on megakaryocytopoiesis and platelet homeostasis in a rat model. Pediatric research, 54(3), 344-352.
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., and Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine. 7(19): 677-696.